7 10 月, 2022

Olympus EU-ME3 Ultrasound Processor Delivers Higher Resolution Images for Endoscopic Ultrasound

TOKYO & HAMBURG, Oct 7, 2022 - (JCN Newswire via SEAPRWire.com) - Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer and more fulfilling, today announced the launch of EU-ME3, a new Endoscopic Ultrasound Processor*, which addresses the needs of healthcare professionals for high-quality clear images when conducting the endoscopic ultrasound procedure. EU-ME3 will be launched in Europe, the Middle East, Africa, parts of Asia, and Oceania within this fiscal year. EU-ME3 will be exhibited during The 30th United European Gastroenterology Week (UEG Week) from October 8 to 11.Olympus announces the global launch of the EVIS EUS Endoscopic Ultrasound Center EU-ME3. [Image: Olympus Corp]As a pioneer in endoscopic ultrasound technology, Olympus aims to leverage its expertise to enhance the care pathway in gastrointestinal and respiratory disease management. The technology is used for endoscopic ultrasonography (EUS) imaging to support the diagnosis of lesions in the pancreas, the bile ducts, or lesions that are located deep inside the body and are not visible with gastrointestinal endoscopes. In addition, the technology enhances the detailed examination of pancreatitis, pancreatic cancer, and the diagnosis of cancer invasion in the stomach and the esophagus. Endoscopic ultrasound also plays a key role in facilitating the visualization of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) for early, minimally invasive diagnosis and lung cancer staging."It is said that pancreatic cancer is difficult to be detected in its early stages, and that lung cancer has the highest mortality rate among all cancers. With the launch of the EU-ME3, Olympus aims to enhance the standard of care including these diseases and to further improve the quality of life of patients," said Hironobu Kawano, Head of Endoscopic Solutions Division at Olympus.Advancing the dimensions of EndosonographyWith the needs of healthcare professionals and patient outcomes at the core, EU-ME3 is tailored to improve a variety of procedures.Enhanced visualization and usabilityEU-ME3 provides outstanding image quality and functionality - the image quality has been substantially enhanced compared to the prior generation model (EU-ME2), providing enhanced visualization, and therefore supporting more reliable diagnosis and treatment. Shear Wave Quantification, a newly equipped feature for EU-ME3, also contributes to accurate diagnosis by providing quantitative information on the stiffness of tumor and inflamed lesions, which is an important factor when diagnosing a degree of pancreatitis and malignancy of pancreatic cancer during endoscopic ultrasonography.Focus on the procedure with tailored technologyThe Endoscopic ultrasound procedure typically utilizes a variety of observation modes dependent on procedure type or clinical area. Subsequently, in addition to the basic observation mode, EU-ME3 offers multiple software options for individual clinical needs, aiming to stay flexible in the selection of functions and tailor EU-ME3 depending on specialty. Smart and customizable user settings make it easy to fulfil needs for multiple specialties and personal requirements. The backlit keyboard includes a simple, easy-to-use large touch panel and trackpad, designed to support better operability and easier cleaning.With EU-ME3, the aim is to provide seamless workflow integration for our partners while advancing the dimensions of endosonography for better overall patient outcome.About OlympusIn its Endoscopic Solutions business, Olympus uses innovative capabilities in medical technology, therapeutic intervention and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic and minimally invasive procedures to improve clinical outcomes, reduce overall costs and enhance the quality of life for patients. Starting with the world's first gastrocamera in 1950, Olympus' Endoscopic Solutions portfolio has grown to include endoscopes, laparoscopes, and video imaging systems, digital and integrated customer solutions, as well as solutions for infection prevention. For more information, visit www.olympus-global.com and follow our global Twitter account: @Olympus_Corp.Media ContactsNao Tsukamoto - Global-Public_Relations@olympus.comJessica Lee - Jessica.yy.lee@fleishman.com* Registered name: EVIS EUS ENDOSCOPIC ULTRASOUND CENTER OLYMPUS EU-ME3. EU-ME3 is manufactured by Olympus Medical Systems Corporation.* Note: Products or devices presented include future technology which may be pending regional regulatory approval and are not available for sale in all regions.Olympus Corp [TYO: 7733] [ADR: OCPNY] [GDR: OLYs] https://www.olympus-global.com Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)

6 1 月, 2021

Olympus and Hitachi Announce Long-Term Business Alliance regarding Endoscopic Ultrasound Systems

TOKYO, Jan 6, 2021 - (JCN Newswire) - Olympus Corporation (TSE:7733) and Hitachi, Ltd. (TSE:6501) have signed a five-year contract to jointly develop Endoscopic Ultrasound Systems (EUS). Hitachi will also continue to supply diagnostic ultrasound systems and related parts used in EUS to Olympus under this contract.EUS consist of a diagnostic ultrasound system and ultrasound flexible endoscopes. They are used in examinations to evaluate the stage of cancer in the liver, pancreas, and bronchus, as well as in minimally-invasive care, contributing to the medical treatment.Hitachi's diagnostic imaging-related business is expected to be transferred to FUJIFILM Corporation, subject to customary closing conditions and regulatory approvals. The agreement between Hitachi and Olympus will be valid after such transfer.Hironobu Kawano, Division Head of the Endoscopic Solutions Division, Olympus Corporation, said, "Olympus aims to improve patients' quality of life through early diagnosis made available with Endoscopic Ultrasound Systems. Our long-standing partnership with Hitachi has built a strong foundation of products and technology development for endoscopic ultrasound diagnosis, and we are very excited to be able to continue this collaboration and contribute further to improving patients' lives. Through this ongoing collaboration, Hitachi and Olympus will introduce products and technology that address the needs of the patients, healthcare professionals and the broader medical industry."Toshihiko Kawano, CTO of Healthcare Business Unit, Hitachi, Ltd., said, "It is our pleasure to continue our collaboration with Olympus in the EUS business. Since the development of the first EUS product in the 1980s, Olympus and Hitachi have always been at the forefront in the market and have contributed significantly to progress the level and quality of treatment for digestive and respiratory diseases around the world. We look forward to collaborating in the future and exploring new clinical values to provide better diagnosis and treatment to patients and healthcare professionals, and contribute to the advancement of medical treatment."About Olympus' Medical BusinessOlympus' Medical business uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients. Olympus' Medical portfolio includes endoscopes, laparoscopes, and video imaging systems, as well as surgical energy devices, system integration solutions, medical services, and a wide range of endotherapy instruments for endoscopic and therapeutic applications. For more information, visit www.olympus-global.com.About Hitachi, Ltd.Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, is focused on its Social Innovation Business that combines information technology (IT), operational technology (OT) and products. The company's consolidated revenues for fiscal year 2019 (ended March 31, 2020) totaled 8,767.2 billion yen ($80.4 billion), and it employed approximately 301,000 people worldwide. Hitachi drives digital innovation across five sectors - Mobility, Smart Life, Industry, Energy and IT - through Lumada, Hitachi's advanced digital solutions, services, and technologies for turning data into insights to drive digital innovation. Its purpose is to deliver solutions that increase social, environmental and economic value for its customers. For more information on Hitachi, please visit the company's website at https://www.hitachi.com. Copyright 2021 JCN Newswire. All rights reserved. www.jcnnewswire.com

21 10 月, 2020

Olympus to Support Endoscopic AI Diagnosis Education for Doctors in India and to Launch the AI Diagnostic Support Application

Participating in Ministry of Internal Affairs and Communications project: "Survey Study for International Expansion of AI Diagnosis Support System Using Ultra-High Magnifying Endoscopes in India" TOKYO, Oct 20, 2020 – (ACN Newswire) – Olympus Corporation took part in a ground-breaking project as a business promoter, in cooperation with the Ministry of Internal Affairs and Communications (MIC), entitled, “Survey Study for International Expansion of AI Diagnosis Support System Using Ultra-High Magnifying Endoscopes in India.” The project aims to develop advanced endoscopy diagnostics in India, where there are relatively few endoscopists. In collaboration with CYBERNET SYSTEMS CO,. LTD., Olympus has established an AI diagnostic support system at a major medical institution, the Asian Institute of Gastroenterology (AIG) based in Hyderabad, India. Specialist lecturers and physicians from Showa University Northern Yokohama Hospital provided expert guidance to AIG doctors. In addition to training AIG doctors in techniques for detecting diseases and differential diagnosis by colonoscope, they also trained the doctors on how to instruct the next generation of endoscopists. The project started on October 12. At the kick-off meeting, Satoshi Hemmi, Deputy Director-General of the Information and Communications Bureau, the Ministry of Internal Affairs and Communications commented, “We hope to contribute to the spread of AI endoscopy systems and the development of medical care in India through training future leaders in AI endoscopy systems in India. We also hope that the cooperation between India and Japan in the field of healthcare ICT will continue to develop.” In addition to the ultra-magnifying scope Endocyto(*1) released last year, Olympus will release endoscopic diagnostic support software equipped with AI in India from December. The endoscopic diagnostic support software EndoBRAIN(*2) and EndoBRAIN-EYE(*3) will be utilized for physician training in India. Olympus intends to assist in the development of physicians and promote the use of endoscopic diagnostics. (*1) An endoscope that enables observation at the cellular level in real time with up to 520 times optical magnification.(*2) AI real-time in-vivo analysis of colon lesions taken with ultra-high magnifying endoscopes, numerically indicating the possibility of neoplastic and non-neoplastic polyps to assist physicians in the differentiation and detection of polyps through figures.(*3) AI endoscopic diagnostic imaging support software that assists physicians in diagnosing lesions by alerting if a polyp or other lesion is detected using regular colonoscope images. Background of Olympus’ Participation In India, the rate of cancer morbidity is expected to increase as the economy grows. On the other hand, there is a severe shortage of doctors who can conduct precision diagnostics with endoscopes, which are essential for early detection and treatment of cancer. Olympus participated in this project to support trained AIG specialists to train doctors in India and neighboring countries and to contribute to the popularization and development of endoscope diagnostics using the latest AI technology. Ministry of Internal Affairs and Communications Project – Purpose:The MIC aims to realize the sustainable development goal and SDG pledges to ensure “no one will be left behind.” To this end, the MIC aims to realize a model that contributes to SDG through digitization and to disseminate and promote an SDG + ICT model domestically and overseas between both public and private sectors. This project aims to contribute to the introduction and dissemination of Japan’s endoscopic AI diagnostic support system to India and neighboring countries in response to the social issue of increasing cancer prevalence in India. – Projects:1) Survey on the Current Status of Policies in the Medical Health Sector in India and the Current Status of the Introduction of Medical ICT in India:Collecting information from major medical institutions and external research institutions and investigating the spread of medical systems, including endoscopic systems. 2) Verification through proof-of-concept tests in India:Physicians from the Showa University Northern Yokohama Hospital will train AIG physicians, from the detection of disease utilizing a colonoscope to discriminatory diagnosis, and train them as lecturers to train instructors. MIC provided equipment and training courses. For questions or additional information, please contact:Yuka Horimoto+81-90-2490-1071yuka.horimoto@olympus.com Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

20 10 月, 2020

Olympus to Support Endoscopic AI Diagnosis Education for Doctors in India and to Launch AI Diagnostic Support Application

TOKYO, Oct 20, 2020 - (ACN Newswire) - Olympus Corporation took part in a ground-breaking project as a business promoter, in cooperation with the Ministry of Internal Affairs and Communications (MIC), entitled, "Survey Study for International Expansion of AI Diagnosis Support System Using Ultra-High Magnifying Endoscopes in India." The project aims to develop advanced endoscopy diagnostics in India, where there are relatively few endoscopists.In collaboration with CYBERNET SYSTEMS CO,. LTD., Olympus has established an AI diagnostic support system at a major medical institution, the Asian Institute of Gastroenterology (AIG) based in Hyderabad, India. Specialist lecturers and physicians from Showa University Northern Yokohama Hospital provided expert guidance to AIG doctors. In addition to training AIG doctors in techniques for detecting diseases and differential diagnosis by colonoscope, they also trained the doctors on how to instruct the next generation of endoscopists.The project started on October 12. At the kick-off meeting, Satoshi Hemmi, Deputy Director-General of the Information and Communications Bureau, the Ministry of Internal Affairs and Communications commented, "We hope to contribute to the spread of AI endoscopy systems and the development of medical care in India through training future leaders in AI endoscopy systems in India. We also hope that the cooperation between India and Japan in the field of healthcare ICT will continue to develop."In addition to the ultra-magnifying scope Endocyto(*1) released last year, Olympus will release endoscopic diagnostic support software equipped with AI in India from December. The endoscopic diagnostic support software EndoBRAIN(*2) and EndoBRAIN-EYE(*3) will be utilized for physician training in India. Olympus intends to assist in the development of physicians and promote the use of endoscopic diagnostics.(*1) An endoscope that enables observation at the cellular level in real time with up to 520 times optical magnification.(*2) AI real-time in-vivo analysis of colon lesions taken with ultra-high magnifying endoscopes, numerically indicating the possibility of neoplastic and non-neoplastic polyps to assist physicians in the differentiation and detection of polyps through figures.(*3) AI endoscopic diagnostic imaging support software that assists physicians in diagnosing lesions by alerting if a polyp or other lesion is detected using regular colonoscope images. Background of Olympus' ParticipationIn India, the rate of cancer morbidity is expected to increase as the economy grows. On the other hand, there is a severe shortage of doctors who can conduct precision diagnostics with endoscopes, which are essential for early detection and treatment of cancer. Olympus participated in this project to support trained AIG specialists to train doctors in India and neighboring countries and to contribute to the popularization and development of endoscope diagnostics using the latest AI technology.Ministry of Internal Affairs and Communications Project- Purpose:The MIC aims to realize the sustainable development goal and SDG pledges to ensure "no one will be left behind." To this end, the MIC aims to realize a model that contributes to SDG through digitization and to disseminate and promote an SDG + ICT model domestically and overseas between both public and private sectors. This project aims to contribute to the introduction and dissemination of Japan's endoscopic AI diagnostic support system to India and neighboring countries in response to the social issue of increasing cancer prevalence in India.- Projects:1) Survey on the Current Status of Policies in the Medical Health Sector in India and the Current Status of the Introduction of Medical ICT in India:Collecting information from major medical institutions and external research institutions and investigating the spread of medical systems, including endoscopic systems.2) Verification through proof-of-concept tests in India:Physicians from the Showa University Northern Yokohama Hospital will train AIG physicians, from the detection of disease utilizing a colonoscope to discriminatory diagnosis, and train them as lecturers to train instructors. MIC provided equipment and training courses.For questions or additional information, please contact:Yuka Horimoto+81-90-2490-1071yuka.horimoto@olympus.com Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com